Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Khan Sharun; Kuldeep Dhama; Shailesh Kumar Patel; Mamta Pathak; Ruchi Tiwari; Bhoj Raj Singh; Ranjit Sah; D. Katterine Bonilla-Aldana; Alfonso J. Rodriguez-Morales; Hakan Leblebicioglu

doi:10.1186/s12941-020-00368-w

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Khan Sharun, Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Bhoj Raj Singh, Ranjit Sah, D. Katterine Bonilla-Aldana, Alfonso J. Rodriguez-Morales, Hakan Leblebicioglu

Producción científica: Artículo Científico › Editorial

113 Citas (Scopus)

Idioma original	Inglés estadounidense
-	23
Publicación	Annals of Clinical Microbiology and Antimicrobials
Volumen	19
N.º	1
DOI	https://doi.org/10.1186/s12941-020-00368-w
Estado	Indizado - 30 may. 2020
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1186/s12941-020-00368-w

Citar esto

@article{52e68878c6a24bbabc0f7b6515eb370d,

title = "Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19",

keywords = "2019-nCoV, COVID-19, Coronavirus, Ivermectin, SARS-CoV-2, Therapeutics",

author = "Khan Sharun and Kuldeep Dhama and Patel, \{Shailesh Kumar\} and Mamta Pathak and Ruchi Tiwari and Singh, \{Bhoj Raj\} and Ranjit Sah and Bonilla-Aldana, \{D. Katterine\} and Rodriguez-Morales, \{Alfonso J.\} and Hakan Leblebicioglu",

year = "2020",

month = may,

day = "30",

doi = "10.1186/s12941-020-00368-w",

language = "American English",

volume = "19",

journal = "Annals of Clinical Microbiology and Antimicrobials",

issn = "1476-0711",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

AU - Sharun, Khan

AU - Dhama, Kuldeep

AU - Patel, Shailesh Kumar

AU - Pathak, Mamta

AU - Tiwari, Ruchi

AU - Singh, Bhoj Raj

AU - Sah, Ranjit

AU - Bonilla-Aldana, D. Katterine

AU - Rodriguez-Morales, Alfonso J.

AU - Leblebicioglu, Hakan

PY - 2020/5/30

Y1 - 2020/5/30

KW - 2019-nCoV

KW - COVID-19

KW - Coronavirus

KW - Ivermectin

KW - SARS-CoV-2

KW - Therapeutics

UR - https://www.scopus.com/pages/publications/85085854178

U2 - 10.1186/s12941-020-00368-w

DO - 10.1186/s12941-020-00368-w

M3 - Editorial

C2 - 32473642

AN - SCOPUS:85085854178

SN - 1476-0711

VL - 19

JO - Annals of Clinical Microbiology and Antimicrobials

JF - Annals of Clinical Microbiology and Antimicrobials

IS - 1

M1 - 23

ER -